<DOC>
	<DOCNO>NCT01925066</DOCNO>
	<brief_summary>The purpose study determine whether aerosolize vancomycin effective treatment methicillin-resistant staphylococcus aureus pneumonia mechanical ventilation .</brief_summary>
	<brief_title>Aerosolized Vancomycin Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Pneumonia , Staphylococcal</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>Nosocomial severe communityacquired pneumonia due MethicillinResistant Staphylococcus aureus Must mechanically ventilate intensive care unit Nonbacterial pneumonia , viral , fungal , tuberculosis infection Underlying respiratory condition : bronchiectasis , posttuberculosis , chronic obstructive pulmonary disease asthma Complicated pneumonia , empyema , parapneumonic effusion require chest tube drainage Already previous treat intravenous vancomycin ( Not pneumonia ) Adverse reaction due inhale ventolin treatment aerosolize vancomycin Hypersensitivity vancomycin glycopeptide antibiotic Positive culture Enterococcus respiratory specimen Pregnant Breastfeeding patient Immunocompromised host : 1mg/kg corticosteroid user 3 month , transplantation recipient , AIDS patient Another aerosolized antibiotic within 48 hour study enrollment Not adherent mechanical ventilation protocol study Not arterial line monitor Vancomycin minimum inhibitory concentration &gt; = 2㎍/㎖ cultured Staphylococcus aureus</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>